GTM

ZoomInfo screens as deep value: at $2.63 the stock trades at 0.6x sales and 6.9x FY2025 diluted EPS of $0.38, against a business that generated $465M of operating cash flow (up 26% YoY) on $1.25B of revenue with 84.0% gross margins and an 18.1% operating margin. Management is leaning hard into that cash: $411M of buybacks in FY2025 shrank the share count 10.8%, and the board authorized another $500M in February 2025 — so even flat fundamentals translate into meaningful per-share accretion. Net income jumped to $124M (+326.8%) and operating income to $226M (+131.7%), partly a rebound from the 2024 SMB bad-debt charge the MD&A flags from the 'new business risk model' deployed in Q2 2024.

The problem is that the top line has gone sideways for three years ($1.24B → $1.21B → $1.25B), and the 10-K all but tells you why: net revenue retention was 90% in 2025 (up from 87%, but still well below the 100% threshold that defines a healthy SaaS book), customer count is 'over 35,000' for the third year running, and $100K+ ACV accounts grew only from 1,867 to 1,921. Management announced a 6% RIF in June 2025 to 'move upmarket,' and drew $100M on the revolver in May 2025 specifically to fund buybacks — financial engineering, not organic growth. R&D was actually cut 7.2% YoY to $182M, which is a yellow flag in a category where Salesforce, HubSpot and AI-native data players are investing aggressively.